Telesky-MCT 25/12.5 combines Telmisartan (40 mg) Chlorthalidone (12.5 mg) and Metoprolol Succinate (25 mg) in an extended-release formulation for comprehensive hypertension management. Telmisartan an angiotensin II receptor blocker helps relax blood vessels while Chlorthalidone a thiazide diuretic reduces fluid retention. Metoprolol a beta-blocker decreases heart rate and workload. This synergistic combination effectively lowers blood pressure and reduces the risk of cardiovascular events promoting overall heart health and improving patient outcomes.









Reviews
There are no reviews yet.